<?xml version="1.0" encoding="UTF-8"?>
<p id="p0190">Another promising drug candidate for coronavirus treatment is ivermectin, which is in phase III clinical trials in dengue patients, quickly avoids replication of SARS-CoV-2 inÂ vitro [
 <xref rid="bib78" ref-type="bibr">78</xref>]. This antiparasitic drug is safe for human use at relatively high doses, is widely available and is a relatively low-cost medicine that prompts further evaluation for possible benefits in COVID-19 patients [
 <xref rid="bib117" ref-type="bibr">117</xref>,
 <xref rid="bib118" ref-type="bibr">118</xref>].
</p>
